2016 | Validation and development of MTH1 inhibitors for treatment of cancer. | Warpman Berglund, U; Sanjiv, K; Gad, H; Kalderen, C; Koolmeister, T; Pham, T; Gokturk, C; Jafari, R; Maddalo, G; Seashore-Ludlow, B; Chernobrovkin, A; Manoilov, A; Pateras, IS; Rasti, A; Jemth, AS; Almlof, I; Loseva, O; Visnes, T; Einarsdottir, BO; Gaugaz, FZ; Saleh, A; Platzack, B; Wallner, OA; Vallin, KS; Henriksson, M; Wakchaure, P; Borhade, S; Herr, P; Kallberg, Y; Baranczewski, P; Homan, EJ; Wiita, E; Nagpal, V; Meijer, T; Schipper, N; Rudd, SG; Brautigam, L; Lindqvist, A; Filppula, A; Lee, TC; Artursson, P; Nilsson, JA; Gorgoulis, VG; Lehtio, J; Zubarev, RA; Scobie, M; Helleday, T | Annals of oncology : official journal of the European Society for Medical Oncology 27(12), 2275-2283 | | | |